Urinary Incontinence

Urinary Incontinence is the indication for 4 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as: Urinary Incontinence (UI) · Incontinence Urinary · Other Specified Urinary Incontinence · Incontinence, Urinary · urinary incontince
Classified under: Musculoskeletal and Connective Tissue Diseases
Nervous System Diseases
Signs, Symptoms, and General Pathologies
Urogenital Diseases
Indicated drugs: Botulinum toxin type A
Flavoxate
Imidafenacin
Propiverine

Resolves to

Vocabularies

MeSHM0022370ICD-10N39.4SNOMED CT129852002MedDRA10005046UMLSC0042024

What you can answer from here — as of October 22, 2026

4Indicated drugsWith each drug's targets and mechanism

Listed above

4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

184Clinical trialsPhase, status and sponsor resolved per trial

100Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Urinary Incontinence share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.